Integrated Report

The report describes Hisamitsu Pharmaceutical Group's FY2024 sustainability performance, including an 18.1% reduction in group CO2 emissions versus FY2013 and a path toward a 2030 reduction target and FY2050 net zero. It reports 2,799 consolidated employees and a 9.4% ratio of women in management positions as of March 31, 2025. The report also documents a formal sustainability governance structure, materiality process, environmental management system, and extensive social and human-rights initiatives.